Exact Sciences
EXAS
#1763
Rank
HK$74.06 B
Marketcap
HK$400.21
Share price
-3.29%
Change (1 day)
-14.24%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : HK$27.06 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are HK$27.06 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$25.97 B4.43%
2022-12-31HK$24.87 B-3.25%
2021-12-31HK$25.71 B23.31%
2020-12-31HK$20.84 B119.85%
2019-12-31HK$9.48 B43.65%
2018-12-31HK$6.60 B981.39%
2017-12-31HK$0.61 B88.6%
2016-12-31HK$0.32 B12.35%
2015-12-31HK$0.28 B55.82%
2014-12-31HK$0.18 B110.83%
2013-12-31HK$87.7 M-16.33%
2012-12-31HK$0.10 B0.29%
2011-12-31HK$0.10 B-19.86%
2010-12-31HK$0.13 B-14.5%
2009-12-31HK$0.15 B136.98%
2008-12-31HK$64.37 M-0.61%
2007-12-31HK$64.76 M-6.53%
2006-12-31HK$69.29 M-32.41%
2005-12-31HK$0.10 B-27.22%
2004-12-31HK$0.14 B-19.05%
2003-12-31HK$0.17 B90.14%
2002-12-31HK$91.53 M184.02%
2001-12-31HK$32.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$2.67 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.79 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.16 B-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$473.00 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France